MC-12, an Annexin A1-Based Peptide, Is Effective in the Treatment of Experimental Colitis

Open Access

Peer-reviewed

Research Article

Nengtai Ouyang,

Affiliation Department of Medicine, Stony Brook University, Stony Brook, New York, United States of America
⨯
Caihua Zhu,

Affiliation Department of Medicine, Stony Brook University, Stony Brook, New York, United States of America
⨯
Dingying Zhou,

Affiliation Department of Medicine, Stony Brook University, Stony Brook, New York, United States of America
⨯
Ting Nie,

Affiliation Department of Medicine, Stony Brook University, Stony Brook, New York, United States of America
⨯
Mae F. Go,

Affiliation VA Salt Lake City Health Care System, Salt Lake City, Utah, United States of America
⨯
Robert J. Richards,

Affiliation Department of Medicine, Stony Brook University, Stony Brook, New York, United States of America
⨯
Basil Rigas

* E-mail: basil.rigas@stonybrookmedicine.edu

Affiliation Department of Medicine, Stony Brook University, Stony Brook, New York, United States of America
⨯

Reader Comments (0)

Colon
Is the Subject Area "Colon" applicable to this article?

Thanks for your feedback.
Transcription factors
Is the Subject Area "Transcription factors" applicable to this article?

Thanks for your feedback.
Inflammation
Is the Subject Area "Inflammation" applicable to this article?

Thanks for your feedback.
Colitis
Is the Subject Area "Colitis" applicable to this article?

Thanks for your feedback.
Cytokines
Is the Subject Area "Cytokines" applicable to this article?

Thanks for your feedback.
Histology
Is the Subject Area "Histology" applicable to this article?

Thanks for your feedback.
Mouse models
Is the Subject Area "Mouse models" applicable to this article?

Thanks for your feedback.
Inflammatory bowel disease
Is the Subject Area "Inflammatory bowel disease" applicable to this article?

Thanks for your feedback.